Guest guest Posted April 3, 2003 Report Share Posted April 3, 2003 Hi, has anyone tried memantine? It's a parkinson's and maybe alzheimer's drug available in europe and probably soon in the US. It was in the news today. It has a lot of properties that make it sound like it might help with CFS. I'm too tired just now to describe what it does. But curious if anyone's tried it, especially any Goldstein patients. michael Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 24, 2003 Report Share Posted May 24, 2003 Hi All, there is info at: www.memantine.com Mike Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 24, 2003 Report Share Posted August 24, 2003 Hi all, has anyone tried memantine (the Alzheimer med)? it's available from Europe and is up for FDA approval. I've heard it may help with cognitive dysfunction and sleep. . . would be great to hear from anyone who's tried it. thanks, michael Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 7, 2006 Report Share Posted December 7, 2006 Anyone ever mention this drug to Dr G? They are doing a study with it and it targets kids with motor planning issues and language issues....that's my guy! K Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 8, 2006 Report Share Posted December 8, 2006 Memantine Study to Target Motor Dysfunction in Autism Cure Autism Now kicks off recruitment for its first Clinical Trials Network study In an effort to explore the possible role of pharmacological treatment of motor deficits in individuals with autism, Cure Autism Now has recently awarded a pilot grant to Evdokia Anagnostou, M.D. from the Seaver and New York Autism Center of Excellence at Mount Sinai School of Medicine. The Mount Sinai team will lead a collaboration of treatment sites in conducting research into the effectiveness of memantine (marketed as Namenda), a compound which modulates the glutamate neurotransmitter system in the brain. Clinically, early data from open label treatment with memantine suggests that it may be helpful in targeting symptoms of motor planning, language, and cognitive function challenges in autism. A randomized multi-center clinical trial of memantine will now be undertaken by the Clinical Trials Network created by Cure Autism Now. The Mount Sinai School of Medicine is the first site to actively enroll subjects. Other clinical trial sites will begin recruiting in the near future. The recruitment periods will vary; for up-to-date information on recruitment for the sites, as well as other studies seeking participants, please check the Clinical Trials/Research Project listing service. Read more about this study in the Science News section of our website. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.